CG Oncology, Inc. Common stockCGONNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-68.14%
Near historical average
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-62.40%
Historical baseline
PeriodValue
2025-68.14%
2024-72.32%
2023-53.26%
2022-118.28%
20210.00%